Kevin M. Foote

2.4k citations

29 papers · 1.6k indexed · h-index 17

Co-authors: Nicholas Keen J. Willem M. Nissink Rajesh Odedra Claire Crafter Alan Lau Gerald Pattenden Frédéric Jung Stephen S. Taylor
Topics: Cancer-related Molecular Pathways (8 papers)DNA Repair Mechanisms (7 papers)Microtubule and mitosis dynamics (7 papers)
Cited by: Cell Biology Oncology Molecular Biology
Journals: Cancer Research Diabetes Clinical Cancer Research
Partner nations: United Kingdom France United States

In The Last Decade

Kevin M. Foote

27 papers receiving 1.6k citations

Peers

Countries citing papers authored by Kevin M. Foote

Since Specialization

Citations

This map shows the geographic impact of Kevin M. Foote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Foote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Foote more than expected).

Fields of papers citing papers by Kevin M. Foote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin M. Foote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Foote. The network helps show where Kevin M. Foote may publish in the future.

Co-authorship network of co-authors of Kevin M. Foote

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Foote. A scholar is included among the top collaborators of Kevin M. Foote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Foote. Kevin M. Foote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improvements in micelle promoted DNA-encoded library synthesis by surfactant optimisation 2025 ·Organic & Biomolecular Chemistry ·(unknown),Matthew J. Anderson,(unknown),Bao N. Nguyen,Kevin M. Foote,Michael J. Waring	0
2	Nationwide, Pragmatic, Direct-to-Patient Primary Aldosteronism Testing Program 2025 ·Hypertension ·Jenifer M. Brown,(unknown),(unknown),(unknown),Anna Moore,(unknown),(unknown),(unknown),(unknown),Kevin M. Foote,Andrew J Newman,(unknown),Anand Vaidya	3
3	Discovery of a novel series of selective macrocyclic PKCTheta inhibitors 2024 ·Bioorganic & Medicinal Chemistry Letters ·Stefano Crosignani,Sébastien Campos,(unknown),Craig S. Harris,Eric P. A. Talbot,Haiyang Hu,Shun Wang,John Maclean,Ugo Zanelli,S. Taylor,Kevin M. Foote,Fériel Hacini‐Rachinel,Edwige Nicodème,Valérie Julia	2
4	Surveillance of the Incidence and Mortality of Oral and Pharyngeal, Esophageal, and Lung Cancer in Nevada: Potential Implications of the Nevada Indoor Clean Air Act 2021 ·International Journal of Environmental Research and Public Health ·Kevin M. Foote,David Foote,Karl Kingsley	2
5	Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival 2016 ·Journal of Medicinal Chemistry ·Jason G. Kettle,(unknown),Michał Biśta,J. Breed,Nichola L. Davies,(unknown),Shaun Fillery,Kevin M. Foote,Louise Goodwin,David R. Jones,Helena Käck,Alan Lau,J. Willem M. Nissink,Jon Read,James S. Scott,Ben Taylor,Graeme E. Walker,Lisa Wissler,Marta Wylot	100
6	An Enantiospecific Polyene Cyclization Initiated by an Enantiomerically Pure Bromonium Ion 2013 ·Chirality ·D. Christopher Braddock,(unknown),Kevin M. Foote,Andrew J. P. White	16
7	Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity 2013 ·Journal of Medicinal Chemistry ·Kevin M. Foote,Kevin Blades,Anna Cronin,Shaun Fillery,(unknown),Lorraine Hassall,Ian Hickson,Xavier Jacq,Philip J. Jewsbury,Thomas M. McGuire,J. Willem M. Nissink,Rajesh Odedra,Ken Page,Paula Perkins,Abid Suleman,Kin Yip Tam,Pia Thömmes,(unknown),Christine Wood	169
8	Abstract 1823: AZ20, a novel potent and selective inhibitor of ATR kinase with in vivo antitumour activity 2012 ·Cancer Research ·Xavier Jacq,Lisa M. Smith,(unknown),Adina Hughes,Rajesh Odedra,Dan Heathcote,Jen Barnes,Steve Powell,Sharon Maguire,(unknown),(unknown),Peter D. Caie,Pia Thömmes,(unknown),Kevin M. Foote,Philip J. Jewsbury,Sylvie M. Guichard	10
9	Fischer synthesis of isomeric thienopyrrole LHRH antagonists 2009 ·Tetrahedron ·David Andrews,(unknown),(unknown),Bénédicte Delouvrié,(unknown),Kevin M. Foote,(unknown),Craig S. Harris,Christine Lambert‐van der Brempt,(unknown),(unknown)	8
10	Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: Selective inhibitors of Aurora B kinase with potent anti-tumor activity 2008 ·Bioorganic & Medicinal Chemistry Letters ·Kevin M. Foote,Andrew Mortlock,Nicola M. Heron,Frédéric Jung,George B. Hill,Georges Pasquet,Madeleine C. Brady,Stephen Green,Simon P. Heaton,(unknown),Nicholas Keen,Rajesh Odedra,Stephen R. Wedge,Robert W. Wilkinson	32
11	Synthesis and structure–activity relationships of thieno[2,3-b]pyrroles as antagonists of the GnRH receptor 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Bénédicte Delouvrié,(unknown),(unknown),Kevin M. Foote,(unknown),Urs J. Hancox,Craig S. Harris,Mike Hutton,(unknown),(unknown)	8
12	AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis 2007 ·Clinical Cancer Research ·Robert W. Wilkinson,Rajesh Odedra,Simon P. Heaton,Stephen R. Wedge,Nicholas Keen,Claire Crafter,John R. Foster,Madeleine C. Brady,Alison Bigley,(unknown),Kate F. Byth,Nigel Barrass,Kirsten Mundt,Kevin M. Foote,Nicola M. Heron,Frédéric Jung,Andrew Mortlock,(unknown),Stephen Green	278
13	Validating Aurora B as an anti-cancer drug target 2006 ·Journal of Cell Science ·Fiona Girdler,Karen E. Gascoigne,Patrick A. Eyers,(unknown),Claire Crafter,Kevin M. Foote,Nicholas Keen,Stephen S. Taylor	228
14	AZD1152: A highly potent and specific aurora kinase inhibitor. 2006 ·Cancer Research ·Robert W. Wilkinson,Nicholas Keen,Rajesh Odedra,Simon P. Heaton,Stephen R. Wedge,Kevin M. Foote,Andrew Mortlock,Frédéric Jung,Nicola M. Heron,Madeleine C. Brady,Mike Walker,(unknown),Nigel Barrass,J. J. Foster,Stephen Green	6
15	Progress in the Development of Selective Inhibitors of Aurora Kinases 2005 ·Current Topics in Medicinal Chemistry ·Andrew Mortlock,Nicholas Keen,Frédéric Jung,Nicola M. Heron,Kevin M. Foote,Robert W. Wilkinson,Stephen Green	19
16	Progress in the Development of Selective Inhibitors of Aurora Kinases 2005 ·Current Topics in Medicinal Chemistry ·Andrew Mortlock,Nicholas Keen,Frédéric Jung,Nicola M. Heron,Kevin M. Foote,Robert W. Wilkinson,Stephen Green	62
17	Synthetic studies towards the phomactins. Concise syntheses of the tricyclic furanochroman and the oxygenated bicyclo[9.3.1]pentadecane ring systems in phomactin A 2003 ·Organic & Biomolecular Chemistry ·Kevin M. Foote,Christopher J. Hayes,Matthew P. John,Gerald Pattenden	43
18	Selective Antagonism of the NPY Y5 Receptor Does Not Have a Major Effect on Feeding in Rats 2002 ·Diabetes ·Andrew V. Turnbull,(unknown),(unknown),Susan Birtles,Scott Boyer,(unknown),(unknown),(unknown),(unknown),(unknown),Kevin M. Foote,J. Elizabeth Pease,M. Block	55
19	Synthesis of the Oxygenated Bicyclo[9.3.1]pentadecane Ring System of Phomactin A using Chromium (II)-mediated Macrocyclisation and Ring Closure Metathesis 2001 ·Synlett ·Kevin M. Foote,(unknown),Gerald Pattenden	27
20	Synthetic studies towards phomactin A. Concise synthesis of the novel tricyclic furanochroman system 1996 ·Tetrahedron Letters ·Kevin M. Foote,Christopher J. Hayes,Gerald Pattenden	43

About Kevin M. Foote

Kevin M. Foote is a scholar working on Cell Biology, Oncology and Toxicology, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (7 papers) and Microtubule and mitosis dynamics (7 papers). The work is most often cited by research in Cell Biology (507 citations), Oncology (621 citations) and Molecular Biology (936 citations). Kevin M. Foote has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Nicholas Keen, J. Willem M. Nissink, Rajesh Odedra, Claire Crafter, Alan Lau, Gerald Pattenden, Frédéric Jung, Stephen S. Taylor, Karen E. Gascoigne and Robert W. Wilkinson. Their work appears in journals such as Cancer Research, Diabetes and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact